ChemicalBook >> CAS DataBase List >>Anagrelide

Anagrelide

CAS No.
68475-42-3
Chemical Name:
Anagrelide
Synonyms
Anagrelida;ANAGRELIDE;Anagrelidum;Anagrelidebase;Anagrelide Monomer;Anagrelide USP/EP/BP;Anagrelide Impurity 25;6,7-dichloro-1,5-dihydroiMidazo 2,1-b quinaz...;6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)one;6,7-dichloro-3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one
CBNumber:
CB8246866
Molecular Formula:
C10H7Cl2N3O
Molecular Weight:
256.09
MDL Number:
MFCD00866794
MOL File:
68475-42-3.mol
MSDS File:
SDS
Last updated:2023-04-23 13:52:06

Anagrelide Properties

Melting point 280 °C
Density 1.77±0.1 g/cm3(Predicted)
storage temp. 2-8°C
pka pKa 2.87 (H2O t=25 I=0.025) (Uncertain);10(H2O t=25 I=0.025) (Uncertain)
Water Solubility slightly soluble
CAS DataBase Reference 68475-42-3(CAS DataBase Reference)
FDA UNII K9X45X0051
NCI Dictionary of Cancer Terms anagrelide
ATC code L01XX35

Pharmacokinetic data

Excreted unchanged in urine <1%
Volume of distribution 12(L/kg)
Biological half-life 1.3 / -

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338

Anagrelide price More Price(11)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
TRC A637303 Anagrelide 68475-42-3 100mg $500 2021-12-16 Buy
Biosynth Carbosynth FA168205 Anagrelide 68475-42-3 50mg $500 2021-12-16 Buy
American Custom Chemicals Corporation API0001487 ANAGRELIDE 95.00% 68475-42-3 1G $811.65 2021-12-16 Buy
AK Scientific K139 Anagrelide 68475-42-3 5mg $49 2021-12-16 Buy
Biosynth Carbosynth FA168205 Anagrelide 68475-42-3 2mg $60 2021-12-16 Buy
Product number Packaging Price Buy
A637303 100mg $500 Buy
FA168205 50mg $500 Buy
API0001487 1G $811.65 Buy
K139 5mg $49 Buy
FA168205 2mg $60 Buy

Anagrelide Chemical Properties,Uses,Production

Originator

Agrylin,Shire Pharmaceuticals

Uses

the treatment of primary thrombocytosis

Uses

Anagrelide; Potent PDE 3 inhibitorIt can be used to inhibit cancer cell invasion.

Definition

ChEBI: A 1,5-dihydroimidazo[2,1-]quinazoline having an oxo substituent at the 2-position and chloro substituents at the 6- and 7-positions.

Manufacturing Process

6,7-Dicloro-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one was produced from 6-chloro-7-bromo-1,2,3,5-tetrahydroimidazo[2,1-b]quinozolin-2-one by substitution the bromine an equimolar quantity chlorine.
6-Chloro-7-bromo-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one was produced next way: to a solution of 1.30 g (8 mmole) of anhydrous ferric chloride in 30 ml of nitromethane was added 1.30 g (5 mmole) of solid 6- chloro-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one and 0.80 g (5 mmole) of bromine. The system was stoppered, warmed to 50°C in an oil bath overnight, cooled to room temperature and the solvent removed in vacuo. The resulting solid was suspended in water (50 ml), the mixture was made basic (pH=10) with sodium bicarbonate and stirred at home temperature for 20 min. The solid was filtered under suction, washed with water, then isopropyl alcohol and dried yielding 1.19 g of 6-chloro-7-bromo- 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one (78% yield). Purification was effected by formation of the hydrochloride salt (mp 275°C) from acetonitrile.
6-Chloro-1,2,3,5,-tetrahydroimidazo[2,1-b]quinazolin-2-one was produced from 6-chloro-2-nitrobenzylchloride, ethylglycine hydrochloride and cyanogen bromide in 3 steps.

brand name

Agrylin (Shire).

Therapeutic Function

Platelet aggregation inhibitor

Clinical Use

Platelet-reducing agent

Enzyme inhibitor

This potent platelet aggregation inhibitor (FW = 256.09 g/mol; CAS 68475-42-3), also known as 6,7-dichloro-1,5-dihydroimidazo[2,1- b]quinazolin-2(3H)-one, BL-4162A, and Agrylin?, blocks the action of a variety of aggregating agents added platelet rich plasma, EC50 < 1 μg/mL, or 4 nM. Primary Mode of Action: Although the exact mechanism of its selective inhibition of megakaryocyte (MK) production of platelets remains uncertain, anagrelide is known to be a potent inhibitor of phosphodiesterase-II (IC50 = 36 nM) and lipoprotein-associated phospholipase A2 (or Lp-PLA2), the latter also known as platelet-activating factor acetylhydrolase (or PAF-AH). PDE-II hydrolyzes both cGMP and cAMP. Binding of cGMP to its regulatory GAF-B domain favors cAMP hydrolysis to 5’-AMP, thereby reducing cGMP hydrolysis to 5’-GMP. This property, which facilitates cross-regulation of the cAMP and cGMP pathways, suggests that a potent PDE-II inhibitor should potentiate the effects of cAMP and/or cGMP, the concentrations of which should increase in anagrelide-sensitive cells. Lp-PLA2 plays pivotal role in platelet maturation by specifically hydrolyzing Platelet-Activating Factor (PAF = acetyl-glyceryl-ether-phosphorylcholine) as well as other glycerophos-pholipids containing short, truncated, and/or oxidized fatty acyl groups at the sn-2 position of the glycerol backbone. At a final concentration of 100 ng/mL, anagrelide selectively blocks in vitro MK maturation, resulting in a 50% decrease in the total number of CD41a+ MKs. In humans, anagreline has the intriguing ability to promote as a species-specific platelet-lowering activity at dose levels lower than those required to inhibit platelet aggregation. Target(s): collagen- and immune complexinduced platelet aggregation and release; suppresses megakaryocytopoiesis by reducing the expression levels of the transcription GATA-1 and FOG-1 via a PDEIII-independent mechanism that is differentiation context-specific but does not involve inhibition of MPL-mediated early signal transduction events.

Drug interactions

Potentially hazardous interactions with other drugs
Aspirin: potential risks and benefits must first be assessed, additive antiplatelet effect.
Cilostazol: avoid concomitant use.
Grapefruit juice: may reduce clearance of anagrelide.
Phosphodiesterase inhibitors: avoid with milrinone and enoximone.

Metabolism

Anagrelide is primarily metabolised by CYP1A2; less than 1% is recovered in the urine as anagrelide. Two major urinary metabolites, 2-amino-5, 6-dichloro-3, 4-dihydroquinazoline and 3-hydroxy anagrelide (pharmacologically active) have been identified. The mean recovery of 2-amino-5, 6-dichloro-3, 4-dihydroquinazoline in urine is approximately 18-35% of the administered dose.

Global( 108)Suppliers
Supplier Tel Email Country ProdList Advantage
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 49390 58
career henan chemical co
+86-0371-86658258 15093356674; factory@coreychem.com China 29826 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29220 58
AFINE CHEMICALS LIMITED
0571-85134551 info@afinechem.com CHINA 15377 58
Wuhan Demeikai Biotechnology Co., Ltd
+8618942921723 info@dmksw.xin China 723 58
Hefei TNJ Chemical Industry Co.,Ltd.
0551-65418684 +8618949823763 sales@tnjchem.com China 25363 58
Hebei Duling International Trade Co. LTD
+8618032673083 sales05@hbduling.cn China 15745 58
LEAP CHEM CO., LTD.
+86-852-30606658 market18@leapchem.com China 24738 58
Nantong HI-FUTURE Biology Co., Ltd.
+undefined18051384581 sales@chemhifuture.com China 3136 58

View Lastest Price from Anagrelide manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Anagrelide pictures 2023-04-20 Anagrelide
68475-42-3
US $50.00 / kg 1kg 99% 50 tons Hebei Duling International Trade Co. LTD
Anagrelide USP/EP/BP pictures 2021-08-05 Anagrelide USP/EP/BP
68475-42-3
US $1.10 / g 1g 99.9% 100 Tons min Dideu Industries Group Limited
Anagrelide pictures 2019-12-31 Anagrelide
68475-42-3
US $7.00 / KG 1KG 99% 100KG Career Henan Chemical Co
  • Anagrelide pictures
  • Anagrelide
    68475-42-3
  • US $50.00 / kg
  • 99%
  • Hebei Duling International Trade Co. LTD
  • Anagrelide pictures
  • Anagrelide
    68475-42-3
  • US $7.00 / KG
  • 99%
  • Career Henan Chemical Co
ANAGRELIDE 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)one 6,7-Dichloro-5,10-dihydro-3H-imidazo[2,1-b]quinazolin-2-one Anagrelidebase 6,7-dichloro-1,5-dihydroiMidazo 2,1-b quinaz... IMidazo[2,1-β]quinazolin-2(3H)-one,6,7-dichloro-1,5-dihydro- 6,7-Dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one Anagrelide analogue: 6-chloro-1,2,3,5-tetrahydro iMidazo [2,1-b]quinazolin-2-one 6,7-dichloro-3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one Anagrelide Impurity 25 Anagrelida Anagrelidum Imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro- Anagrelide USP/EP/BP Anagrelide 13C2-15N-D2Q: What is Anagrelide 13C2-15N-D2 Q: What is the CAS Number of Anagrelide 13C2-15N-D2 AnagrelideQ: What is Anagrelide Q: What is the CAS Number of Anagrelide Q: What is the storage condition of Anagrelide Q: What are the applications of Anagrelide Anagrelide Monomer 68475-42-3 Pharmaceutical intermediate